chr7-30599996-A-G
Variant summary
Our verdict is Likely pathogenic. Variant got 6 ACMG points: 6P and 0B. PM2PM5PP3_Moderate
The NM_002047.4(GARS1):c.374A>G(p.Glu125Gly) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. E125K) has been classified as Pathogenic.
Frequency
Consequence
NM_002047.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_pathogenic. Variant got 6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
GARS1 | NM_002047.4 | c.374A>G | p.Glu125Gly | missense_variant | 3/17 | ENST00000389266.8 | NP_002038.2 | |
GARS1 | NM_001316772.1 | c.212A>G | p.Glu71Gly | missense_variant | 3/17 | NP_001303701.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
GARS1 | ENST00000389266.8 | c.374A>G | p.Glu125Gly | missense_variant | 3/17 | 1 | NM_002047.4 | ENSP00000373918.3 | ||
GARS1 | ENST00000675651.1 | c.374A>G | p.Glu125Gly | missense_variant | 3/17 | ENSP00000502513.1 | ||||
GARS1 | ENST00000675810.1 | c.272A>G | p.Glu91Gly | missense_variant | 2/16 | ENSP00000502743.1 | ||||
GARS1 | ENST00000675693.1 | c.206A>G | p.Glu69Gly | missense_variant | 4/18 | ENSP00000502174.1 | ||||
GARS1 | ENST00000675051.1 | c.173A>G | p.Glu58Gly | missense_variant | 3/17 | ENSP00000502296.1 | ||||
GARS1 | ENST00000674815.1 | c.5A>G | p.Glu2Gly | missense_variant | 3/17 | ENSP00000502799.1 | ||||
GARS1 | ENST00000674851.1 | c.5A>G | p.Glu2Gly | missense_variant | 4/18 | ENSP00000502451.1 | ||||
GARS1 | ENST00000444666.6 | n.374A>G | non_coding_transcript_exon_variant | 3/18 | 3 | ENSP00000415447.2 | ||||
GARS1 | ENST00000674616.1 | n.*88A>G | non_coding_transcript_exon_variant | 4/18 | ENSP00000502408.1 | |||||
GARS1 | ENST00000674643.1 | n.374A>G | non_coding_transcript_exon_variant | 3/17 | ENSP00000501636.1 | |||||
GARS1 | ENST00000674737.1 | n.374A>G | non_coding_transcript_exon_variant | 3/18 | ENSP00000502464.1 | |||||
GARS1 | ENST00000674807.1 | n.374A>G | non_coding_transcript_exon_variant | 3/16 | ENSP00000502814.1 | |||||
GARS1 | ENST00000675529.1 | n.*244A>G | non_coding_transcript_exon_variant | 4/18 | ENSP00000501655.1 | |||||
GARS1 | ENST00000675859.1 | n.374A>G | non_coding_transcript_exon_variant | 3/15 | ENSP00000502033.1 | |||||
GARS1 | ENST00000676088.1 | n.*244A>G | non_coding_transcript_exon_variant | 4/19 | ENSP00000501884.1 | |||||
GARS1 | ENST00000676140.1 | n.374A>G | non_coding_transcript_exon_variant | 3/17 | ENSP00000502571.1 | |||||
GARS1 | ENST00000676164.1 | n.374A>G | non_coding_transcript_exon_variant | 3/17 | ENSP00000501986.1 | |||||
GARS1 | ENST00000676210.1 | n.374A>G | non_coding_transcript_exon_variant | 3/18 | ENSP00000502373.1 | |||||
GARS1 | ENST00000676259.1 | n.374A>G | non_coding_transcript_exon_variant | 3/17 | ENSP00000501980.1 | |||||
GARS1 | ENST00000676403.1 | n.374A>G | non_coding_transcript_exon_variant | 3/16 | ENSP00000502681.1 | |||||
GARS1 | ENST00000674616.1 | n.*88A>G | 3_prime_UTR_variant | 4/18 | ENSP00000502408.1 | |||||
GARS1 | ENST00000675529.1 | n.*244A>G | 3_prime_UTR_variant | 4/18 | ENSP00000501655.1 | |||||
GARS1 | ENST00000676088.1 | n.*244A>G | 3_prime_UTR_variant | 4/19 | ENSP00000501884.1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 31
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Charcot-Marie-Tooth disease type 2D Pathogenic:1Uncertain:1Other:1
Uncertain significance, no assertion criteria provided | literature only | Inherited Neuropathy Consortium Ii, University Of Miami | Jan 06, 2016 | - - |
not provided, no classification provided | literature only | GeneReviews | - | GARS1-HMSN (CMT2D & dSMA-V) [Antonellis et al 2003, He et al 2015] - |
Pathogenic, no assertion criteria provided | literature only | OMIM | Nov 01, 2014 | - - |
Neuronopathy, distal hereditary motor, type 5A Pathogenic:1
Pathogenic, no assertion criteria provided | literature only | OMIM | Nov 01, 2014 | - - |
Charcot-Marie-Tooth disease Uncertain:1
Uncertain significance, no assertion criteria provided | literature only | Inherited Neuropathy Consortium | - | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at